Aytu Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Aytu Biopharma

17/05/2021 22:41

* Aytu Biopharma Inc  AYTU.OQ  reported a quarterly adjusted
loss of $1.41​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 31 cents per share.
* Revenue rose 65.3% to $13.48 million from a year ago; 
analysts expected $14.07 million. 
* Aytu Biopharma Inc's reported EPS for the quarter was a loss
of $1.41​.
* The mean earnings estimate of analysts had risen by
about 45.2% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Aytu Biopharma Inc shares had fallen by 29.1% this quarter and
lost 9.9% so far this year.
* The company reported a quarterly loss of $25.46 million.
* Wall Street's median 12-month price target for Aytu Biopharma
Inc is $19.25 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 17 at 09:41 p.m. GMT.
​All figures in US dollars